Hong Kong’s Aprinoia Therapeutics to go public via SPAC merger

Hong Kong’s Aprinoia Therapeutics to go public via SPAC merger

Photo by Pepi Stojanovski on Unsplash

Mars W. Mosqueda Jr.

19 January, 2023

Aprinoia TherapeuticsRoss Acquisition Corp II

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.